Hematology and oncology (Q508): United States public contracts since 2024

Updated 17 October 2026 · all lines

Hematology and oncology (Q508): United States public contracts since 2024. Since January 2024 the line carries 84 contracts worth $14,094,961 from 3 agencies. 24 suppliers share it. $5,575,334 in 2024. $5,701,267 in 2025. $2,818,361 in 2026.

Assay record ASY-US-1AYHYB50GT · Cite as: Assay Systems, “Hematology and oncology (Q508): United States public contracts since 2024”, https://assay-systems.com/register/us/line/hematology-and-oncology/

The line

Since January 2024 the line carries 84 contracts worth $14,094,961 from 3 agencies. 24 suppliers share it.

$5,575,334 in 2024. $5,701,267 in 2025. $2,818,361 in 2026.

Suppliers in the line, by value since 2024

The extract for this line

Names every department and buying office behind the figures, who holds each contract now, its value, contract number and end date, the open notices with their closing dates, and the notices behind every figure.

Largest suppliers in the line

Share of the line held by each of its largest suppliers, by value, in the USAspending register.

NATIONAL MARROW DONOR PROGRAM20.0%CREATIVE TESTING SOLUTIONS12.2%GREATER METROPOLITAN COMMUNITY BLOOD SE…11.2%POSTERITY GROUP LLC9.2%PROMETHEUS FEDERAL SERVICES LLC9.0%THE UNIVERSITY OF IOWA7.5%TOSOH BIOSCIENCE, INC.5.6%NEW YORK BLOOD CENTER, INC4.8%RAPID TEMPS, LLC4.1%RENAL TREATMENT CENTERS - SOUTHEAST LP3.7%

All suppliers in United States, A to Z

Source: USAspending.gov, U.S. Department of the Treasury, Bureau of the Fiscal Service, usaspending.gov, accessed 30 September 2026.The data is available to copy, adapt, redistribute, or otherwise use for non-commercial or for commercial purposes (USAspending.gov, Licensing); no Dun & Bradstreet data is shown.